TARSUS PHARMACEUTICALS, INC. (TARS) Free cash flow 2019–2025
TARSUS PHARMACEUTICALS, INC. (TARS) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$22.3MFY2025 · since FY2019: -$3.8M → -$22.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$22.3M | +73.6% |
| FY2024 | -$84.6M | +28.9% |
| FY2023 | -$119.0M | -140.2% |
| FY2022 | -$49.5M | -1666.6% |
| FY2021 | $3.2M | +114.6% |
| FY2020 | -$21.6M | -461.2% |
| FY2019 | -$3.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice